Royal Preston Hospital

Preston, Lancashire PR29H

1 studies enrolling now · 6 studies all time

What they study most

Advanced or Metastatic NRAS-mutant Melanoma, Breast Cancer, Enteric Hyperoxaluria, Hyperoxalemia, Magnetic Resonance Imaging, Metastatic or Unresectable Cutaneous Melanoma, Primary Hyperoxaluria

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) — Running, not enrolling
• Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia — Completed